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ABSTRACT 
Early detection and treatment of cancers have increased survival and improved clinical outcome. The 
development of metastases is often associated with a poor prognostic of survival. Finding early markers of 
metastasis and developing new therapies against their development is a great challenge. Since a few years, 
there is more evidence that ionic channels are involved in the oncogenic process. Among these, voltage-
gated sodium channels expressed in non-nervous or non-muscular organs are often associated with the 
metastatic behaviour of different cancers. The aim of this review is to describe the current knowledge on the 
functional expression of voltage-gated sodium channels and their biological roles in different cancers such 
as prostate, breast, lung (small cells and non-small cells) and leukaemia. In the conclusion, we develop 
conceptual approaches to understand how such channels can be involved in the metastatic process and 
conclude that blockers targeted toward these channels are promising new therapeutic solutions against 
metastatic cancers.  
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Introduction 
Cancers are among the leading causes of death in the world and as such represent a major problem of public 
health. This is the reason why governments, pharmaceutical companies, industrials and academics are all so 
intensely involved in a better understanding of the etiologies of the diseases. Such efforts aim at the 
improvement in the early detection of tumours in order to propose more efficient treatments. These could be 
effective in replacement of or in association with other therapies used presently. One of the new promising 
fields of investigation is the pharmacology of ionic channels which are known to be involved in different 
aspects of the carcinogenic process. Among ionic channels, voltage-gated sodium channels (VGNaC) make 
the topic of this review. These channels consist of a highly processed  subunit, which is approximately 260 
kDa, associated with at least two auxiliary  subunits as displayed in figure 1 [1]. Sodium channels in the 
adult central nervous system contain 2 plus either 1 or 3 subunits, while sodium channels in adult skeletal 
muscle have only the 1 subunit. The pore-forming  subunit is sufficient for functional expression, but the 
channel and current density, kinetics and voltage-dependence of gating are modified by the  subunits [2]. 
A new 2-related subunit called 4 was recently discovered but its possible interaction with the pore-
forming  protein is not described yet [3]. Ten genes encoding VGNaC  subunits have been identified and 
nine of these have been functionally studied in expression systems. Among these potent ten isoforms, nine 
constitute a single family named NaV1 according to their phylogeny and are designated NaV1.1 to NaV1.9 
[4,5]. The remaining isoform, NaX, shows a structure diverging from the NaV1 family and seems to be gated 
by sodium concentration and not by voltage. Based on their tetrodotoxin (TTX) sensitivity, VGNaC are 
classified as TTX-sensitive or TTX-S (NaV1.1 to NaV1.4, NaV1.6 and NaV1.7) and TTX-resistant or TTX-R 
(NaV1.5, NaV1.8 and NaV1.9). VGNaC are classically described as critical elements of action potential 
initiation and propagation in excitable cells because they are responsible for the initial depolarisation of the 
membrane. However, these channels are also known to be expressed in non excitable cells such as T-
lymphocytes [6].  
To investigate the expression of proteins like ionic channels, techniques such as RT-PCR and 
immunoblot allow to determine the presence of mRNA and their translation into proteins. However, one 
state-of-the-art technique exists, namely the patch-clamp technique [7], which allows to quantify the activity 
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of these proteins. Displacement of ions from one compartment to another leads to the generation of a current 
due to the electric charges borne by the ions. The patch-clamp technique uses a glass pipette as an electrode 
to measure the electric current flowing through the ionic channels. Since the ionic flux depends mainly on 
passive diffusion, changes in current amplitude directly reflect the changes in channel conformation and 
thus activity. The two major configurations to measure currents flowing through all the channels of an 
isolated cell, and thus called whole cell recording, are the "ruptured patch" (the membrane patch at the tip of 
the pipette is broken and the intracellular content is replaced by the medium present into the pipette) and the 
"perforated patch" (antibiotics such as amphotericin B present in the pipette medium form pores, into the 
membrane trapped at the tip of the pipette, to get an electrical access to the interior of the cell while 
reducing the dilution of intracellular soluble molecules).  
 To study some aspects of cancers, cultured cell lines are generally used. Different aspects of their 
biology can refer to different aspect of the disease. For example, cell proliferation in vitro can be an index of 
the kinetics of tumour proliferation in vivo. The facilities with which the cells migrate through filters, 
covered or not with Matrigel (mimicking the extracellular matrix) are considered as indexes of invasion 
and migration, respectively. These parameters are both involved in the metastatic properties of the cells. 
Even if metastatic properties do not depend on cell invasiveness only, extracellular matrix invasion is a 
prerequisite to get metastases. The evaluation of the capacity of cells to produce metastases can be assessed 
by injecting the cells into nude mice. Understanding this aspect of the disease is very important because it is 
the main cause of death by cancer. Metastasis can be summarised as a process whereby cells escaping from 
a primary tumour enter circulation (blood or lymph), migrate and become lodged at tissue-specific or non-
specific sites where they proliferate to form secondary tumours. To escape the primary tumour and to set in 
a distant site, tumour cells need to produce, or induce host cells to produce, proteases (e.g. matrix 
metalloproteases, MMP) to degrade the extracellular matrix. 
 
 
Prostate cancer 
We will first review the involvement of VGNaC in prostate cancer (PCa) because, thanks mainly to 
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the group of Mustafa Djamgoz in London, it is the best understood one in term of mechanisms description.  
PCa is the most frequently diagnosed male cancer and the second most common cause of death of 
men from cancer in Western societies [8]. The first study of a sodium current measured in patch-clamp 
conditions was made in a rat prostate cancer cell line [9]. In this paper, the authors describe the activity of 
sodium channels only in a highly metastatic cell line, Mat-Ly-Lu, but not in the weakly metastatic one, AT-
2. This current is fully blocked by 1µM TTX suggesting that it is a TTX-S. Proliferation was not affected by 
TTX. Since the currents were recorded in the metastatic cell line, the authors investigated its possible 
involvement in the metastatic process using an in vitro Matrigel invasion chamber assay. Incubation of the 
Mat-Ly-Lu cells with 600 nM TTX for 48h reduced their invasive capacity by 33 %. In contrast, TTX had 
no significant effect on the invasiveness of the AT-2 cell line. Later on, the same group performed similar 
experiments in human prostate cancer cell lines, PC-3 and LNCaP, and found similar results [10]. It must be 
underlined that in both studies [9, 10], the authors report that not all cells investigated in patch-clamp 
possess functional sodium channels. This led these authors to further investigate the relationship between 
protein expression and invasiveness [11]. This study was performed in both rat and human cell lines in 
which the expression of VGNaC was assessed by flow cytometry using a fluorescein-labelled polyclonal 
antibody. Weakly metastatic cell lines such as AT-2 and LNCaP displayed almost no expression of VGNaC. 
On the opposite, highly invasive cell lines such as PC3 and Mat-Ly-Lu displayed bimodal frequency 
distribution profiles with a subpopulation of cells expressing high levels of sodium channel protein. 
Comparison of the degree of sodium channels expression with the capacity of the different cell lines to 
invade Matrigel shows a significant positive correlation. In addition, two transfected cell lines, obtained 
by transfecting genomic DNA from rat prostatic tumour cells into a recipient benign cell line (non invasive), 
were found to express significantly elevated levels of sodium channel protein compared to the original cell 
line. This enhanced expression was correlated with increased invasiveness in vitro. The only uncorrelated 
observation in this study is that PNT2 cell line, which is reported to be benign, contains numerous sodium 
channels. This expression could be subsequent to the transfection with the SV40 genome. It also could mean 
that cells need more channels than the amount expressed in PNT2 to become invasive [11]. It has also been 
speculated that the presence of the channels gives the potential for invasion but this is prevented by local 
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factors or the need for other essential criteria such as accumulation of other mutations [11]. Whatever the 
reason, it must be noticed that, to our knowledge, there was no attempt to determine the functional activity 
of the channels in PNT2 cells. 
 Bennet et al (2004) compared a weakly metastatic human cell line, LNCaP, and two increasingly 
tumorogenic daughter cell lines, C4 and C4-2. They showed that the increasing invasiveness of the C4 and 
C4-2 cell lines was related with an increasing level of VGNaC proteins measured by immunobloting [12]. 
TTX at 1 µM completely reversed the difference in invasiveness between C4, C4-2 and LNCaP cell lines. 
Moreover the transient expression of the skeletal isoform (NaV1.4) of the channel in the 3 cell lines 
increased their invasive capacity in a TTX-sensitive manner. From their work, it can be concluded that 
sodium channels expressed are sufficient for the invasivity of prostate cancer cells. 
 
TTX sensitivity of VGNaC 
 In a very elegant study, the electrophysiological and pharmacological properties of Mat-Ly-Lu cells 
current have been characterised [13]. The only powerful blocker found was TTX with an IC50 of about 18 
nM (see table I). Such sensitivity makes this channel a TTX-S. 
  
Isoform(s) of the channel(s) 
 The question of the isoforms expressed was addressed both in Mat-Ly-Lu (rat) and PC3 (human) cell 
lines. These cells express mRNA coding for the skeletal isoform SkM1 now named NaV1.4 [14]. In situ 
hybridation experiments indicated that the levels of mRNA expression were very variable from cell to cell 
in Mat-Ly-Lu cells. In contrast, this signal was more uniform in AT-2 cells although at much lower levels. 
In the same vein, LNCaP cells also expressed NaV1.4 mRNA. In that study, they did not find any mRNA 
expression for NaV1.1 (also called RB I), NaV1.2 (RB II), NaV1.3 (RB III), Nax (NaG/SCL-11) and NaV1.6 
(Na6) in any of the cell lines tested. It was concluded that all cell lines expressed VGNaC mRNA although 
the channel was functional only in highly metastatic cell lines [14]. However, the authors noticed that the 
pharmacological properties of the functional protein were particular since 10 µM µ-conotoxin was needed 
to completely block the current while nM concentrations are usually enough to block the skeletal sodium 
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current (see also [13]). This surprising result led the authors to re-investigate this point using other 
molecular biology methods (degenerate primer screening and semi-quantitative PCR) on the same cell lines 
[15]. They found that the main mRNA isoform expressed in Mat-Ly-Lu and PC3 cells was NaV1.7 and this 
was thus likely to be the main source of the functional VGNaC detected. However, other isoforms are 
observed such as NaV1.1, NaV1.2, NaV1.4 (see table I and figure 2A).  
 Interestingly, NaV1.4 has been transiently expressed in LNCaP, C4 and C4-2 cells lines [12]. In each 
cell line, transient expression of the channel induced a large increase in invasiveness which was completely 
reversed by 1 µM TTX. This result confirms the role played by sodium channel in the invasion process. 
Above all, this result indicates that, even if NaV1.7 seems to be the channel primarily involved in invasive 
properties of rat and human prostate cancer cell lines, other isoforms of the channel can render cells 
invasive.  
 
Biological consequences of sodium channels activity 
 To address this important question, the group of Mustafa Djamgoz tested three different cellular 
processes important to PCa metastasis: galvanotaxis, motility and invasion.  
 I - Galvanotaxis is the ability of cells to respond to an electric field by moving directionally. Such a 
property is known to be involved in a number of basic biological process such as embryonic development 
[16] but also in other physiological conditions such as wound healing [17]. To evaluate this properties, Mat-
Ly-Lu and AT-2 cells were exposed to exogenous direct-current electric fields of physiological strength 
[18,19]. In these conditions, it has been shown that highly metastatic Mat-Ly-Lu cells responded to the 
application of an electric field by migrating towards the cathode. AT-2 cells gave no such response. The 
migration of Mat-Ly-Lu cells was blocked by 1 µM TTX while 10 µM veratridine, a sodium channel 
opener, enhanced it. This study thus showed that galvanotaxis of metastatic cells is under the control of the 
VGNaC activity. The precise mechanisms involved in this particular case are not understood but some 
hypotheses have been put forward based on other cases (see [20]). 
 II - Motility is an integral component of the metastatic cascade and involves sub-cellular 
mechanisms like changes in cell volume, cell-matrix interaction, cytoskeletal elements and ion channels 
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activity. In 1999, Fraser et al. [21] found that VGNaC activity played a significant role in determining the 
morphological development of Mat-Ly-Lu cells. Later on, the same group completed this observation by 
showing that lateral motility of these cells, assessed using a "wound-heal" assay, was significantly reduced 
with 1 µM TTX [22]. Quite surprisingly, 20 µM veratridine did not affect motility of these cells while 
aconitine (100 µM) and ATXII (25 pM), two other "sodium-openers", increased it. At this concentration, 
veratridine did not affect cell proliferation while at 50 µM, proliferation was reduced [23]. The lack of 
effect of veratridine could be due to its interaction with other ionic channels [22]. 
 III – Before cells migrate into the local circulation and then interact with other particular tissues to 
form a secondary tumour, the extracellular matrix has to be digested. This is done by proteases such as 
matrix metalloproteases (MMPs) (see [24] for review). In vitro, this property, called invasiveness, is 
evaluated through the potency of cells to migrate through filters coated with a film of Matrigel. An 
indirect way to evaluate the capacity of cells to release proteases by exocytosis is to measure the secretory 
membrane activity. This was done by Mycielska et al. who measured the uptake of horseradish peroxidase 
(HRP) [25]. Since the recycling of membrane constituents requires close matching between the levels of 
endocytosis and exocytosis, HRP uptake is a marker of secretory membrane activity. Mat-Ly-Lu cells have 
a higher activity than AT-2 cells [25]. This difference is abolished in presence of 1 µM TTX while 
veratridine did not increase the activity in Mat-Ly-Lu cells. To explain this surprising result, it has been 
proposed that the VGNaC would be working at maximal efficiency [25]. From these results, different 
hypotheses were proposed to link the VGNaC activity to the increased membrane trafficking as illustrated 
on figure 2B. One hypothesis was that Na
+
 influx could disrupt intracellular pH which would lead to a 
release of Ca
2+ 
from intracellular stores. This Ca
2+
 could then activate protein kinase C and/or CaM kinase II 
and lead to phosphorylation of the actin cytoskeleton thereby allowing secretion and endocytosis to occur. 
An alternative hypothesis is that a direct action of Na
+
 on adenylate cyclase could alter levels of cAMP 
which activates protein kinase A. The changes in actin cytoskeleton phosphorylation would similarly allow 
secretion and endocytosis. 
Since veratridine affects VGNaC dependent parameters such as galvanotaxis without affecting others 
like motility and membrane secretory activity, it appears that the relationship between the channels activity 
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and the final effects is rather complex as is the dependence of membrane secretory activity when analysed 
by fractal methods [26]. This might mean that motility and secretory activities are already maximal and thus 
cannot be enhanced by an increase in VGNaC activity. 
 One of the major functions of normal prostate gland is the synthesis, accumulation and secretion of 
large amounts of citrate [27]. During the progression of malignancy, the intermediate metabolism of citrate 
is altered. This can have important implications on cellular bioenergetics, cell growth and apoptosis, 
angiogenesis [27]. The mechanism of citrate release by human normal prostatic cells, PNT2-C2, has been 
studied [28]. They found that these cells functionally express an electrogenic citrate transporter which 
mediates the cotransfert of 1 citrate (trivalent anion) alongside 4 K
+
 out of the cells. A similar study was 
also performed in a highly metastatic cell line, PC-3M [29]. The K
+
/citrate cotransporter found in PNT2-C2 
cells was also found in PC-3M cells. However, PC-3M cells also expressed a novel Na
+
-dependent citrate 
transporter. Interestingly, the expression of this transporter was controlled by the VGNaC activity: treatment 
of the cells with 1 µM TTX induced a reduction of the activity of the Na
+
-dependent transporter while the 
K
+
-dependent transporter activity increased. The contribution of the citrate transporters to metastatic disease 
has to be understood to determine their interplay with VGNaC activity. 
 
 The diagram shown on figure 2B underlines a very important unresolved question: how does sodium 
enter the cells through the channel ? Usually, VGNaC are opened following a depolarisation leading to the 
triggering of an action potential. In the case of cancer cells, it has been proposed that metastatic prostate 
cancer cells membrane are "potentially electrically excitable" since they express both sodium and potassium 
voltage-gated channels [30]. However, such action potentials have never been observed, spontaneously or 
triggered, weakening such a hypothesis. An explanation might arise in view of some electrophysiological 
properties of the channel (see the Breast cancer section). 
  
Regulation of prostate cancer VGNaC  
Cancer cells are very sensitive to the chemical conditions of the in vivo environments encountered 
during tumorigenesis and metastatic spread (see in [30]). Among them Nerve Growth Factor (NGF) and 
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Epidermal Growth Factor (EGF) have been associated with prostate cancer progression and have also been 
found to up-regulate VGNaC expression (see [30]). Such factors can be found in the serum used to grow 
cells in culture. Using Mat-Ly-Lu cells, it was shown that, depending on the serum concentration used to 
grow cells, the electrophysiological properties of the current varied, suggesting both transcriptional and 
post-transcriptional regulations of the channel. Interestingly, the sensitivity of the current to TTX also 
varied [30]. This has been interpreted by the authors as a possible regulation of the expression of the 
different mRNA isoforms. This finding is of importance since weakly metastatic cells often express mRNA 
for VGNaC (see table I). It is thus possible that changes in the surrounding environment, such as an increase 
in growth factors, can amplify the functional expression of VGNaC rendering the cells more invasive. 
 
Expression of VGNaC in patients 
 Up-regulations of VGNaC in PCa have been shown in two studies. In the first one, an antibody 
directed against an intracellular epitope of VGNaC was used on tissue microarray slides of 80 clinical PCa 
specimens and 4 normal prostate specimens [31]. Out of 80 PCa specimens, 44 showed higher levels of 
VGNaC compared to normal, with 14 (of 44) showing increased focal staining in scattered individual cells 
or small group of cells. It thus appears that the observations obtained in prostate cancer cell lines are 
pertinent with those made in PCa tumour specimens: in prostate cancer, an increased level of expression of 
the VGNaC is observed. Very recently, another study went further by showing that the level of expression 
of the mRNA coding for NaV1.7 is related with the grade of PCa: the higher the grade, the higher the 
expression of NaV1.7 mRNA [32]. Thus, the expression of NaV1.7 has been proposed to be a potential novel 
marker for human prostate cancer [32]. 
 These results led some research groups to develop new molecules targeted against VGNaC in order 
to block their activity (see [33] for review). This underlines the interest these channels might have as new 
therapeutic targets. The problems with these studies are that: (i) the VGNaC isoform tested (NaV1.2) has not 
been shown to participate in invasion [34] and (ii) the cellular function evaluated (proliferation) is not 
affected by the functional expression of VGNaC [33, 34]. 
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Breast cancer 
 Among women, breast cancer is the most common cancer and the first cause of death. Death occurs 
primarily after the development of metastasis. Until the beginning of the XXI
st
 century, the studies on ionic 
channels and breast cancer focused mainly on potassium channels and their involvement in proliferation 
[35-39]. Also, the role of the Ca
2+
 -activated chloride channel, coded by the CLCA2 gene, was also studied 
with regard to tumour metastasis [40]. It was found that it was a tumour repressor. All these studies showed 
that ionic channels can be involved in breast cancer genesis. 
 In the beginning of the 2000’s, two different research groups, our group in Tours and the one of 
Mustafa Djamgoz in London, showed at the same time that VGNaCs were expressed in a highly metastatic 
breast cancer cell line, MDA-MB-231 [41,42]. As shown on figure 3A, the electrophysiological 
characteristics of the current are not particular except for the voltage activating threshold (voltage at which 
the channel starts opening) which is more positive than in the case of the cardiac current. This might be 
related either to the foetal vs adult isoform (see below) or to a particular arrangement with auxiliary  
subunits. For example it is known that co-expression of 1 with NaV1.5 in HEK293 cells induces a positive 
shift of the activation and inactivation curves, associated with a slowing of the reactivation [43]. 
 The current recorded in MDA-MB-231 cells was not observed in two other cell lines, MCF-7 and 
MDA-MB-468. MCF-7 cells are weakly invasive in vitro and non-metastatic in nude mice. MDA-MB-468 
cells have an invasive capacity similar to that of MDA-MB-231 cells [41] but are less metastatic [44]. Like 
in PCa, it seems that VGNaC participates to invasion in vivo leading to higher metastatic potentials. 
 
Pharmacological profile of VGNaC 
The pharmacology of the sodium channel expressed in MDA-MB-231 cells is rather particular [41, 
45]. While its TTX sensitivity is consistent with a TTX-R isoform of the channel (see Table I), the channel 
is surprisingly also sensitive to some calcium channel blockers with IC50 of 53.2 ± 3.6 µM for diltiazem and 
37.6 ± 2.5 µM for verapamil, which are concentrations classically used to block calcium channels [45]. The 
VGNaC mainly expressed in these cells if the foetal isoform of NaV1.5 [46]. This could explain the 
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particular pharmacology of the channel. This finding could also bring another explanation why verapamil 
was beneficially used along with conventional chemotherapy [47]. In that study, verapamil was used as a 
chemoresistance inhibitor. We propose that it could also have worked as a VGNaC blocker. 
 
Isoform(s) of the channel(s) 
Semi-quantitative RT-PCR showed that NaV1.5, NaV1.6 and NaV1.7 mRNA are expressed in MDA-
MB-231 cells [46, 48]. The low TTX sensitivity of the channel (IC50  2 µM [41]) strongly suggests that the 
main isoform functionally expressed is NaV1.5. However, a minor expression of a functional TTX-S 
isoform has been also suggested [46]. 
 
Biological consequences of sodium channels activity ? 
To evaluate the role of this channel, the specific blocker of the VGNaC, TTX was used. Since the 
NaV1.5 is a TTX-R channel, 30 µM of TTX was used to block all the channels [41]. This elevated 
concentration of TTX has never been shown to affect other proteins activity, or more generally, other 
biological activity than VGNaC. Neither cell proliferation nor migration was affected by the blockade of 
VGNaC. On the other hand, in vitro invasion was reduced by about 30% in MDA-MB-231 cells and it was 
not changed in MCF-7 and MDA-MB-468 cells, which do not express such functional channels (figure 3B). 
Similar results were obtained in a more recent study using 10 µM TTX [46]. Conversely, invasion was 
increased by the "sodium-opener" veratridine (unpublished data) reinforcing the potential role of VGNaC in 
invasion. It thus seems that the activity of the channels participates in the degradation of the Matrigel. 
Other properties involved in the metastatic process such as galvanotaxis, exocytosis and lateral 
motility have been shown to be under the control of the VGNaC activity [46]. Regarding cell migration 
through filters with calibrated pores, results are discrepant. In one study, no effect of 30 µM TTX on 
transwell migration through 8 µM diameter pores was reported [41]. Moreover, we performed wound-
healing assays with MDA-MB-231 cells and found no effect of TTX (unpublished data). In contrast, the 
group Djamgoz found that transwell migration through 12 µM diameter pores was inhibited partially by 10 
µM TTX [46]. Since a similar reduction was observed in an in vitro invasion assay, the results obtained by 
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Fraser et al. [46] suggest that the main effects of VGNaC activity are exerted through modifications of cell 
motility while in the case of Roger et al. [41], the only effect is through the modulation of the capacity of 
cells to degrade Matrigel. This apparent discrepancy has no obvious explanation.  
 
Regulation of breast cancer VGNaC  
The sodium channel expressed in MDA-MB-231 cells can be regulated but the precise mechanisms 
are still unknown. The configuration of the patch-clamp used to study the channel was reported to affect 
some electrophysiological characteristics of the sodium current (figure 3C) [47]. The ascending limb of the 
I-V curve (from -60 to -10 mV) was shifted leftward in ruptured patch compared to perforated patch 
conditions and this was associated with slower kinetics of recovery of the channel from inactivation. 
Interfering effects on signalling pathways with the patch-clamp configuration have been observed in cardiac 
cells and have been attributed to intracellular content dilution [48]. The observations made in the breast 
cancer cell line were thus interpreted as a consequence of the dilution of a factor involved in a signalling 
pathway such as the PKC pathway, induced by the intracellular perfusion in ruptured patch-clamp. Other 
dedicated experiments have to be performed to evaluate how the expression of the channel is regulated by 
environmental factors such as growth factors. 
 
Expression of VGNaC in patients 
 The relationship between the expression of the channel mRNA with lymph node invasion has been 
studied [46]. It was found that patients with lymph node invasion, determined using anatomo-pathological 
techniques, expressed mRNA for NaV1.5 while those who were negative for lymph node invasion did not 
express mRNA for this VGNaC. This correlation was not observed for NaV1.6 and NaV1.7. The 
immunohistochemical staining of human breast tissues for the NaV1.5 indicates no staining in normal tissues 
while a strong heterogeneous staining was observed in cancerous tissues [46]. These findings suggest that 
the expression of neonatal NaV1.5 can be used as a prognostic factor of metastatic development. The 
development of a neonatal specific antibody directed against the neonatal isoform of NaV1.5 has been 
undertaken [49]. 
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These results strongly suggest that the observation made in a highly metastatic cancer cell line, 
MDA-MB-231 are not restricted to a cell line but can be transposed to the evolution of the disease. The 
particular isoform of the channel expressed, associated with its unusual pharmacology suggests that a 
particular treatment targeted toward this channel, without side effects on cardiac function, can be developed. 
 The unanswered question is still: how are VGNaC involved in the invasive phenotype of these cells 
? We proposed that, since it has never been possible to record an action potential, the membrane potential of 
MDA-MB-231 cells would have to be in a particular range of the sodium channel activity. Indeed, at that 
potential (-29 ± 2 mV, n= 65 cells), the sodium channel is partially activated and not fully inactivated [41]. 
The resulting ionic current is called a window current. What is important is that, even without any action 
potential, the partial opening of the channel leads to a continuous entry of sodium into the cell. This entry 
might be responsible for the increased intracellular sodium concentration observed in biopsies [52] which in 
turn can modulate other homeostases such as calcium or proton. After those changes, the consequences on 
cell physiology can be the same as the one presented on figure 2B which concerns prostate cancer cells. 
 
 
Lung cancers 
Lung cancer is the most common cancer over the world, with more than one million cases of death a 
year. It is divided in two major histopathological groups: non-small cell lung cancer and small cell lung 
cancer which occur with frequencies of 80% and 20% respectively [53].  Small cell lung cancer affects 
mainly non smokers and is characterised by rapidly proliferating tumours and poor prognosis. This cancer is 
often associated with a neuromuscular autoimmune disease characterised by the insufficient release of 
acetylcholine from the motor nerve terminal [54] and known as the Lambert-Eaton myasthenic syndrome. 
Non-small cell lung cancer is the very widespread kind of lung cancer which is associated with smoking. 
The occurrence of metastases, initially appearing in lymph nodes and then in other organs such as lung 
itself, brain, bone, bone marrow, liver, adrenal glands, is always a marker of poor prognosis. 
 
 Small cells 
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 Small-cell lung cancer cells have been shown to be neuroendocrine-like cells capable of producing 
action potentials [55]. This discovery has been reinforced by others who suggested that small-cell lung 
cancer cells derived from primitive endodermal cells which differentiate into neuroendocrine cells [56]. 
Later, the ionic channels expressed in different cell lines (H128, H69 and H146) were characterised and 
VGNaC were found to be expressed in all of them [57]. These VGNaC and a calcium current also present 
were able to elicit action potentials [58]. Both channels were blocked by autoimmun antibodies responsible 
for the Lambert-Eaton syndrome. 
The sodium channels expressed in H146 cells were weakly sensitive to TTX (Ki=215 nM) (see 
figure 4A) [58]. From their analysis of electrophysiological and pharmacological characteristics, they 
determined that only one population of TTX-resistant sodium channels was expressed. Since these cells are 
neuroendocrine-like and since they are able to produce action potentials, it is tempting to assume that they 
are involved in excitation-secretion coupling function. However, as noticed by Blandino et al. [58], the 
resting membrane potential of the H146 cells was approximately –44 mV, a level sufficient to inactivate 
most of the Na
+
 channels (see figure 4B). Either the resting membrane potential of this kind of cells is 
actually more hyperpolarised in tumours than it was measured in H146 or these sodium channels are not 
involved in the elicitation of action potentials [58]. In that latter case, we propose an alternative hypothesis 
described in the conclusion section. 
In a recent study, it has been observed that in H69 and other small-cell lung cancer cell lines (H209 
and H510), 100 nM TTX reduced Horse Radish Peroxidase uptake suggesting a role for VGNaC in the 
exocytic activity [59]. However, the presence of functional VGNaC has not been undertaken in H209 and 
H510 cells and other properties involved in the metastatic phenotype have not been evaluated. 
 
 Non small cells 
 To our knowledge, no electrophysiological study ever evaluated the presence of VGNaC in this kind 
of cells except for a paper we recently submitted [59]. Some of the results presented in this paper are 
summarised here. In this study, 4 cancer cell lines (H23, H460, A549, Calu-1) and 2 non-cancerous 
epithelial cell lines (NL-20, BEAS-2B) were tested. While the non-cancerous cells did not have functional 
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channels as measured in patch-clamp conditions, three cancer cell lines (H23, H460 and Calu-1) expressed 
functional channels with different electrophysiological and pharmacological properties (see Table I).  
 
TTX sensitivity of VGNaC 
The most striking difference between the cell lines concerns the isoforms expressed functionally, as 
determined by their TTX sensitivity. This sensitivity was in the nanomolar range in H23 and H460 cells. 
Thus the protein isoforms belonged to TTX-S in these cell lines. For Calu-1 cells, there were clearly two 
kinds of channels expressed: TTX-R and TTX-S. In contrast with the other cancers described in this review, 
the heterogeneous sensitivity to TTX indicates heterogeneity in isoforms expression between cell lines. 
 
Isoforms of the channels 
 Semi-quantitative RT-PCR experiments indicated that all the studied cell lines (cancerous and non-
cancerous) expressed mRNA for the NaV1.6 and NaV1.7 isoforms which are both TTX-S. In the case of H23 
and H460 cells, NaV1.7 mRNA was more abundant and were possibly responsible for the expressed 
functional channels. However, a possible expression of NaV1.6 cannot be rejected. These cells express 
mRNA for the NaV1.5 isoform but the TTX sensitivity of the current suggests that it was not functionally 
expressed. Calu-1 cells expressed mRNA for all the isoforms except for NaV1.4. The most abundant mRNA 
was, in descending order, those of NaV1.7, NaV1.6, NaV1.5, NaV1.1 and NaV1.3. The particular 
pharmacology of the current, which is clearly both TTX-R and TTX-S, indicates that the NaV1.5 is 
functionally expressed. With regard to TTX-S, the situation is more complicated since mRNA for NaV1.6, 
NaV1.7 and NaV1.1 are comparably expressed and a possible participation of NaV1.3 cannot be rejected. 
 Knowing that non-cancerous cells, NL-20 and BEAS-2B, express mRNA for NaV1.6 and NaV1.7, 
plus NaV1.5 for the latter, like the cancerous cell lines, but did not have functional proteins, it is tempting to 
speculate that these cells have the potential to functionally express these VGNaC but they miss something to 
do it. 
 
Biological control of sodium channels activity 
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The effect of µM TTX on proliferation, migration and Matrigel invasion was tested on the 6 
different cell lines [56]. We followed the same protocols that we previously used on breast cancer cell lines 
[41]. In all cell lines, TTX had no effect on proliferation and migration. An effect was only observed when 
TTX was applied and Matrigel invasion evaluated. In that case, a reduction of invasion between 40 to 
50% was observed in H23, H460 and Calu-1 cells which functionally express the VGNaC. Calu-1 cells 
express functional TTX-S and TTX-R VGNaC. Application of different concentrations of TTX blocking 
TTX-S or TTX-S + TTX-R VGNaC led to a gradual reduction of in vitro invasion. This indicates that both 
kinds of channels are involved in the invasion properties of the cells.  
 
Expression of VGNaC in patients 
 In an unpublished study, we performed semi-quantitative RT-PCRs on 10 cancerous and associated 
non-cancerous lung biopsies collected from the same patients. The mRNA coding for the 9 isoforms of NaV 
were tested. In contrast to what could be expected from the cell line experiments, we did not observe an up-
regulation of NaV mRNA expression. Rather, there is a tendency for a down-regulation. These results 
indicate that mRNA expression was modified during the disease. Nothing is known about their translation in 
proteins and VGNaC activity. This is of importance since we found that only VGNaC activity is important 
in the invasion process. Cross-talks have been described between the functioning of VGNaC and mRNA 
production. For example, the application of 1 µM TTX to rat prostatic cancerous cells Mat-Ly-Lu increased 
the production of mRNA coding for the VGNaC [29]. Thus, we can hypothesise that a reduction in mRNA 
can result in a decreased channel activity but also that it is a consequence of an increased channel activity. 
Additional experiments at the functional level, using patch-clamp, are needed to elucidate this question.  
 
 
Leukaemia 
 There are few studies about the role of VGNaC in leukaemia. The first one was a brief description 
showing that the leukaemia cancer cell line K562 expressed a VGNaC [61]. During the same period of time, 
another research group, using the same cell line, did not find this current except in particular conditions in 
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which cells became resistant to anticancerous drugs (MDR phenotype) [62]. This current was blocked by 
nM TTX (Ki<100 nM). While the functional expression of the sodium current was clearly associated with 
the MDR phenotype, it was not involved in the resistance to chemotherapy since 1 µM TTX had no effect 
on vincristine (an anticancerous drug) uptake. 
 Following this work, leukaemia cell lines from T-cell origin were studied: CCRF-CEM and a MDR 
variant CEM/VLB100 [63]. Contrarily to the work of Yamashita et al. [62], they found that a sodium current 
was observed in both cell lines and as such was not associated with the MDR phenotype. Here again, the 
current was sensitive to TTX (Ki<150 nM).  
 In conclusions of these three studies, there is no clear link between VGNaC activity and the MDR 
phenotype. Moreover, the role of VGNaC, if there is one, is not described in these studies. Interestingly, a 
recent study showed that 8-9 % of Jurkat cells, a cell line derived from normal T-lymphocytes, expressed a 
sodium current [64]. This study confirmed the presence of a sodium current on T-lymphocytes and T-
lymphocytes-derived cell lines [6]. This current is blocked by TTX with a Ki around 900 nM and as such 
can be classified as TTX-resistant. RT-PCR analysis indicates the presence of mRNA for at least 4 isoforms 
of VGNaC, two of them being TTX-R, NaV1.5 and NaV1.9. NaV1.8 was not detected and for the authors, the 
protein which is most likely expressed is NaV1.5. The mRNA coding for NaV1.6 and NaV1.7 were also 
observed but to a lesser extent. Interestingly, Matrigel invasion assays on Jurkat cells were performed 
[64]. In control conditions, about 8% of the cells were invasive, close to the percentage of cells expressing 
an electrophysiologically detectable sodium current. Following treatment with 10 µM TTX, invasiveness 
was decreased by approximately 93% (see figure 5). This suggests that the observation of a sodium current 
in leukaemia cells might not be due to a neo-synthesis of VGNaC but to an up-regulation of already 
expressed channels (see conclusions for development). 
 
 
General conclusions 
As shown on Table I, functional expression of VGNaC (mainly NaV1.7, NaV1.6 and NaV1.5) is often 
associated with invasive properties of some cancer cell lines. VGNaC are also expressed in biopsies from 
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metastatic patients. VGNaC are classically described as being responsible of the excitability and 
propagation of the action potential. This is why the presence of VGNaC is often interpreted as an indication 
of possible excitability whatever the tissue in which it is found. However, in cancer cells, the membrane 
potential is less negative than it is in excitable cells. This strongly suggests that the channels must be 
partially inactivated. The membrane potential of cancer cells is often, if not always, located in a window of 
voltage where there is a continuous entry of sodium owing to a partial activation and incomplete 
inactivation of VGNaC (see figure 4). This led us to hypothesise that such an entry of sodium could be 
responsible for an increase in intracellular calcium which can then enhance the release of proteases [41], in 
accordance with results obtained on prostatic cancer cells [25]. This hypothesis, which needs further 
experiments to be strengthened, reconciles a lot of data in the literature in which the window current at the 
cellular membrane potential, although not determined, can be inferred from the illustrations. Another 
hypothesis can be proposed such as changes in intracellular pH (pHi). Intracellular sodium regulates pHi 
through the activity of the sodium-proton exchanger and the sodium-bicarbonate exchanger. Indeed, it is 
known that many proteins involved in the metastatic process are tightly regulated by the surrounding pH 
[25]. In the case of PCa, VGNaC activity regulates a specific sodium-dependent citrate transport [29]. 
However, this is one aspect of the physiology which is particular to the prostate functioning. The regulation 
of invasion by VGNaC activity strongly suggests that there is a regulation of proteases or growth factors 
release and/or activity which is common to all the cancers described. 
Beside its effect on motility and invasion, the sodium channels can have other roles which are 
important in the process of metastatic tumour development. Indeed it is often reported that among highly 
invasive cell lines (as determined in vitro), those which express the VGNaC are more metastatic when 
injected in nude mice than are those which lack the VGNaC. This feature might be brought by the adherence 
properties of auxiliary -subunits such as the 2 [65]. Indeed, 2 can help migrating cells to settle in specific 
metastatic site (e.g. lung, bones) and then invade this tissue to develop the secondary tumour. 
A question arises considering that VGNaC can be expressed in different cancer cells and in very few 
"normal" cells. Does this expression represent dedifferentiation towards a more embryonic phenotype? It 
has been proposed that embryonic genes, which are silent in the cells of the mature organ, are re-expressed 
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in cancer cells [66]. In line with this hypothesis, the splice variant of VGNaC expressed in prostate and 
breast cancers are neonatal (see [67]). This hypothesis is also reinforced by the observation that cultured 
normal cells (smooth muscle cells, retinal pigment epithelial cells) express VGNaC while freshly isolated 
cells do not [68-72]. From the literature regarding the role of VGNaC in cancer cells, it seems that its main 
role is to participate in the invasive capacity of the cells. We can thus assume that VGNaC are expressed in 
cells during particular events of embryogenesis. For example, during the embryonic development, cells need 
to migrate and invade to find the nest where the organ can develop. The invasion before nesting can be due 
to the production of proteases which are, at least partially, under the control of a VGNaC. After the nesting 
of the cells, the no longer necessary genes encoding the VGNaC can be switched off. Mutations during 
carcinogenesis might lead to the switch on of the silent genes. It is known that some regions of the 
chromosomes are more sensitive to mutations like deletions. For example, it has been reported that in renal, 
breast and lung carcinomas, there are frequent deletions in chromosome 3p21.3 [73-74]. The 3p21 region 
contains numerous genes including NaV1.5 and NaV1.9 (see [4]). It is thus possible that the probability to 
have mutations leading to the oncogenic process is higher in chromosome regions corresponding to genes 
active during the fœtal period. If this hypothesis is true, it could explain the fœtal-splice form expressed in 
some cancer cells and the overall specificity of the isoform expressed in some cancers (for example NaV1.5 
in breast cancer and NaV1.7 in prostate cancers).  
In conclusion, VGNaC are found in several metastatic cancers and their functional expression may 
represent a more generic involvement in physiological and pathophysiological invasive processes. These 
ionic channels probably interfere with calcium homeostasis which in turn modifies signalling pathways 
involved in invasiveness, a prerequisite to metastasis formation. As such, these channels, as fœtal isoforms, 
represent a promising new field of investigations to develop new specific blockers to fight some metastatic 
cancers. 
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Figure 1 
 
 
 
Figure 1: Subunit structure of the voltage-gated sodium channels. The secondary structures of the  and  
subunits of the voltage-gated sodium channels are illustrated as transmembrane folding diagram. Cylinders 
represent probable alpha helical segments. The different important parts of the channel are indicated 
(voltage-sensing, pore, modulation, inactivation and interaction with drugs). P indicates sites of 
demonstrated protein phosphorylation by protein kinase A (circles) and protein kinase C (diamond). Sites of 
binding of - and -scorpion toxins are shown. Reprinted from [1] with permission from Elsevier. 
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Figure 2 
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Figure 2: VGNaC in prostatic cancer cells. A, expression levels of the various VGNaC  subunits indicated 
below the bars. In each case, the vertical axis denotes the approximate level of expression with respect to 
mRNA levels in the highly metastatic counterpart. B, Schematic diagram of the possible mechanisms 
modulating membrane vesicle recycling involving Na
+
 influx resulting from VGNaC (VGSC) activity. The 
scheme illustrates possible down-stream and microdomain effects of rising intracellular Na
+
. Intracellular 
sodium can affect intracellular calcium and pH. Both modulations of homeostasis could in turn modify the 
activity of kinases involved in exocytoses. Abbreviations: ER, endoplasmic reticulum; IP3/Ryn, inositol 
triphosphate and/or ryanodine receptor. The "kinase" may be protein kinase A, C or CaM kinase II. A from 
[15] and B from [25]. Reprinted with permission of Wiley-Liss Inc, a subsidiary of John Wiley & Sons, Inc. 
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: VGNaC in breast cancer cells. A, sodium current-voltage relationship of MDA-MB-231 cells. 
The inset on the left shows a family of currents recorded from a cell depolarised, from a holding potential of 
–100 mV, from –50 to +20 mV by 5 mV increments. B, relative effects of 30µM TTX on Matrigel 
invasion of three different breast cancer cell lines as compared to control. C, influence of the patch-clamp 
configuration on sodium current-voltage relationship. The inset shows an example of currents recorded from 
cells depolarised at –10 mV from a holding potential of –100 mV in perforated patch (PP) and ruptured 
patch (RP). A and B from [41] reprinted with permission from Elsevier; C from [50] with kind permission 
of Springer Science and Business Media. 
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Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: VGNaC in small cell lung cancer cells. Voltage dependent sodium currents recorded from H146 
cells. A, whole-cell currents were evoked from depolarizing test potentials of 40 ms duration varying from –
30 to +10 mV with 10 mV increments. The holding potential was –80 mV. Left, current observed in control 
conditions and the right panel illustrates current traces obtained in presence of 100 nM TTX. B, Pseudo-
steady-state activation (m) and inactivation (h) parameters of INa. From [58] with kind permission of 
Springer Science and Business Media . 
A 
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Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: VGNaC in T-lymphocytes (Jurkat cells). A, From a holding potential of –100 mV, a 30 msec test 
pulse to –10 mV every 10 sec elicits a rapid inward current which is not very sensitive to 200 nM (i) and 2 
µM (ii) TTX. B, Semi-quantitative PCR gel images for (i) NaV1.5, (ii) NaV1.6, (iii) NaV1.7 and (iv) NaV1.9 
products amplified from Jurkat cells. PCR cycle numbers for given bands are indicated above the gels.  
denotes the mis-transcribed/exon-skipped form of NaV1.6. C, Matrigel invasiveness by Jurkat cells under 
control conditions (dark bar) and following treatment with 10 µM TTX (light bar).  The asterisks (***) 
indicate that the difference was statistically significant (p<0.001). From [63] with the permission of the 
authors. 
 
 
A B 
C 
 Cancer type Cell lines mRNA  
expression 
TTX sensitivity Functional 
expression 
VGNaC Role VGNaC 
in 
Biopsies 
References 
Prostate PC-3  NaV1.7 
NaV1.2 
NaV1.3 
8.6 nM fNaV1.7  Invasion 
Motility (G) 
Motility (WH) 
Yes 
(IH) 
 
[10, 15, 31] 
 LnCaP  NaV1.2  No current   [10, 15] 
 Mat-Ly-Lu (rat) NaV1.7 
NaV1.1 
NaV1.4 
18 nM fNaV1.7  Invasion 
Motility (G) 
Motility (WH)  
?  
[9, 13, 15] 
 AT-2 (rat) NaV1.1 
NaV1.4 
NaV1.9 
 No current  
--- 
 
--- 
 
[9, 15] 
Normal  
(immortalised) 
PNT-2  ?  No current --- --- [28] 
        
Breast MDA-MB-231 NaV1.7 
NaV1.5 
NaV1.6 
2 µM fNaV1.5  Invasion Yes 
(RT-
PCR) 
 
[41, 46] 
 MCF-7 NaV1.5 
NaV1.6 
NaV1.7 
 No current  
--- 
 
--- 
 
[41] 
 MDA-MB-468 ?  No current   [41] 
Normal  
(long term primoculture) 
HMEC  NaV1.6 
NaV1.7 
NaV1.2 
? Tiny current Unknown 
(non invasive cells) 
 Personal data  
(not shown) 
        
Small-Cell Lung Cancer H146 ? 215 nM Current ? ? [57, 58] 
 H128 ? ? Current ? ? [57] 
 H69 ? ? Current Endocytosis ? [57,59] 
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Non-Small Lung Cancer H460 NaV1.7 
NaV1.6 
NaV1.5 
NaV1.3 
10 nM NaV1.7 
NaV1.6  
Invasion Yes 
(RT-
PCR) 
[60] 
 Calu-1 NaV1.7 
NaV1.6 
NaV1.5 
NaV1.1 
NaV1.2 
NaV1.3 
NaV1.9 
NaV1.8 
5 nM + 1 µM NaV1.5  
 
NaV1.7  
NaV1.6  
NaV1.1  
NaV1.2  
NaV1.3  
Invasion  [60] 
 H23 NaV1.7 
NaV1.6 
NaV1.5 
10 nM NaV1.7  
NaV1.6 
Invasion  [60] 
 A549 NaV1.6 
NaV1.7 
 No current --- --- [60] 
Normal 
(immortalised) 
NL20 NaV1.7 
NaV1.6 
NaV1.2 
NaV1.3 
 No current --- --- [60] 
Normal 
(immortalised) 
BEAS-2B NaV1.5 
NaV1.7 
NaV1.1 
NaV1.6 
 No current --- --- [60] 
        
Leukaemia K562 ? ? Current ? ? [61] 
 K562   No current --- --- [62] 
 K562/ADM ? <100 nM Current ? ? [62] 
 CCRF-CEM ? <150 nM Current ? ? [63] 
 CEM/VLB100 ? <150 nM Current ? ? [63] 
Normal 
(immortalised) 
Jurkat NaV1.5 
NaV1.7 
NaV1.9 
 900 nM NaV1.5 NaV1.5   
[64] 
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Table I: List of the non-central nervous system cancers in which VGNaC have been studied. Cell lines indicates the human cancer cell lines used (except 
when "rat" is indicated in brackets); mRNA expression indicates the mRNA coding for the channels sorted in order of decreasing intensity as determined by 
semi-quantitative RT-PCR; TTX sensitivity indicates the constant of inhibition of the current by TTX; functional expression indicates the isoform of the 
channel which likely bears the current measured in patch-clamp. If a current was recorded but the isoform not determined then it is indicated "Current"; 
VGNaC role indicates the role of the channel in vitro as determined after inhibition by TTX. G indicates motility assessed by galvanotaxis; WH indicates 
motility assessed by wound-healing assay; VGNaC in biopsies indicates the presence or not of the mRNA (RT-PCR) or protein (immuno-histochemistry, 
IH) in biopsies obtained from patients. "?": not determined or unknown. 
 
